CN105368851B - A kind of omega-3 desaturase derived from Phytophthora parasiticus, carrier containing said desaturase, recombinant microorganism and application thereof - Google Patents
A kind of omega-3 desaturase derived from Phytophthora parasiticus, carrier containing said desaturase, recombinant microorganism and application thereof Download PDFInfo
- Publication number
- CN105368851B CN105368851B CN201510902579.5A CN201510902579A CN105368851B CN 105368851 B CN105368851 B CN 105368851B CN 201510902579 A CN201510902579 A CN 201510902579A CN 105368851 B CN105368851 B CN 105368851B
- Authority
- CN
- China
- Prior art keywords
- desaturase
- saccharomyces cerevisiae
- recombinant
- fatty acid
- invsc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010033653 omega-3 fatty acid desaturase Proteins 0.000 title abstract description 38
- 244000005700 microbiome Species 0.000 title abstract description 7
- 241000233614 Phytophthora Species 0.000 title description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 31
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 31
- 241000894006 Bacteria Species 0.000 abstract description 22
- 230000003197 catalytic effect Effects 0.000 abstract description 15
- 241000233629 Phytophthora parasitica Species 0.000 abstract description 12
- 230000015572 biosynthetic process Effects 0.000 abstract description 12
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract description 10
- 238000006555 catalytic reaction Methods 0.000 abstract description 6
- 150000007523 nucleic acids Chemical group 0.000 abstract description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 4
- 239000000969 carrier Substances 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 41
- 238000006243 chemical reaction Methods 0.000 description 30
- 239000002609 medium Substances 0.000 description 20
- 239000000758 substrate Substances 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- 241000233866 Fungi Species 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- 239000002775 capsule Substances 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000006180 TBST buffer Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 241000219112 Cucumis Species 0.000 description 3
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229910009891 LiAc Inorganic materials 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 3
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 3
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229960002668 sodium chloride Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 108700010070 Codon Usage Proteins 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108010087894 Fatty acid desaturases Proteins 0.000 description 2
- 102000009114 Fatty acid desaturases Human genes 0.000 description 2
- 206010020466 Hunger Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 238000010818 SYBR green PCR Master Mix Methods 0.000 description 2
- 241000235342 Saccharomycetes Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 235000010598 long-chain omega-6 fatty acid Nutrition 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000024188 Andala Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 1
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- IPVSQRLZENDNRL-KVVVOXFISA-N hexadecanoic acid;(z)-octadec-9-enoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O IPVSQRLZENDNRL-KVVVOXFISA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 244000038651 primary producers Species 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- -1 sulphur threoses Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to recombinant nucleic acid sequence, the carriers containing ω -3 desaturase, the especially recombinant Saccharomyces cerevisiae bacterium of the recombinant microorganism containing the carrier of coding phytophthora parasitica ω -3 desaturase of such as SEQ ID NO.3, further relate to the construction method of recombinant Saccharomyces cerevisiae bacterium, and purposes of the saccharomyces cerevisiae containing the desaturase in polyunsaturated fatty acid biosynthesis, it at normal temperature can be by C20:4Δ5,8,11,14Catalysis is C20:5Δ5,8,11,14,17, catalytic efficiency reaches 65%.
Description
[technical field]
The invention belongs to technical field of bioengineering, relate to the use of Microbe synthesis polyunsaturated fatty acid, and in particular to
A kind of ω -3 desaturase for synthesizing polyunsaturated fatty acid, contains the load at the carrier containing ω -3 desaturase
The recombinant microorganism of body and its application.
[background technique]
Long-chain polyunsaturated fatty acid (LC-PUFAs) refers to the how unsaturated rouge containing 20 or 20 or more carbon atoms
Fat acid, the position according to first double bond apart from C-terminal can be divided into ω -6 and ω -3 liangs of class.ω -3LC-PUFAs nothing in human body
Method voluntarily synthesizes, and needs to obtain from diet, belongs to essential fatty acid, such as EPA and DHA.The study found that using EPA and DHA as generation
ω-the 3LC-PUFAs of table can be used as the precursor substance for synthesizing certain hormones, have the function of multiple physiological and potential medicinal valence
Value.So far, the source of ω -3LC-PUFAs is based on abyssal fishes, however the LC-PUFAs therefrom extracted but has stabilization
The disadvantages of property is poor, purifying process is complicated, oxidizable.In recent years, microorganism is as a kind of new source LC-PUFAs just by more
Come more extensive concern: marine algae is grown by autotrophy, heterotrophism and mixotrophic mode, and growth cycle is short, be EPA and
One of the primary producer of DHA and the most potential source ω -3LC-PUFAs;The research costs such as saccharomycete, mould are low, suitable
Large-scale production and genetic background detail are closed, the potentiality for producing a variety of LC-PUFAs are possessed.With molecular biology and biological skill
More and more sight have been invested oil-producing fungi by the rapid development of art, people, to which thallus fat is transformed by genetic engineering
Sour synthesis path produces EPA, DHA, but due to low efficiency is inferior, and commercialization is still not implemented so far.
ω -3LC-PUFAs is usually synthesized by LA and ALA starting in nature, by a series of desaturases and extends enzyme
Catalysis, ultimately forms EPA and DHA.Wherein, ω -3 desaturase is one of the key enzyme in ω -3LC-PUFAs synthesis process,
Tool, can be by omega 6 polyunsaturated fatty acid such as LA (C18:2), GLA (C18:3), DGLA there are three the structural domain for being rich in histidine
(C20:3) and ARA (C20:4) be catalyzed respectively generate corresponding omega-3 polyunsaturated fatty acids ALA (C18:3), SDA (C18:
4), ETA (C20:4) and EPA (C20:5).
The study found that ω -3 desaturase of separate sources there is different catalysis to imitate the fatty acid of different carbon chain lengths
Rate.At present it is known that ω -3 desaturase from algae and plant can only be catalyzed the omega 6 polyunsaturated fatty acid of 18C such as
LA and GLA.And it then can be simultaneously with the how unsaturated rouge of 18C and 20C from the ω -3 desaturase FAT 1 of Caenorhabditis elegans
Fat acid is substrate, but wherein very low to the catalytic activity of 20C substrate.Then, Pereira et al. discovery is from different branch water mold
Omega-fatty acid desaturase sdd17 does not have catalytic activity to the polyunsaturated fatty acid of 18C, but can be by the ARA of 20C catalysis
EPA, conversion ratio 25.9%.Likewise, ω -3 desaturase the OPIN 17 from phytophthora infestans can not be with the more of 18C
Unsaturated fatty acid is substrate, but has reached 30.94% to the conversion ratio of ARA.
In recent years, Xue et al. from melon and fruit corruption mould, soyabean phytophthora, that three kinds of ω -3 are isolated in robur sudden death pathogen is de- full
And enzyme --- PaD 17, PsD 17 and PrD 17 simultaneously realize heterogenous expression (Identification in recombination solution rouge saccharomycete
and characterization of newΔ-17fatty acid desaturases,Appl Microbiol
Biotechnol(2013)97:1973–1985).These three enzymes can be catalyzed 18C but also be catalyzed the polyunsaturated fatty acid of 20C,
But preference is catalyzed 20C substrate A RA.By to these preferences be catalyzed 20C desaturase further study show that, at normal temperature
There is higher conversion ratio to ARA, realizes biological accumulation EPA under room temperature.This kind of preferences are using 20C ω -6LC-PUFAs substrate
The desaturase for catalyzing and synthesizing ω -3LC-PUFAs can directly, efficiently be catalyzed ARA and generate EPA, for by extending enzymatic
Synthesis DHA provides substrate, and biological synthesis process production ω -3LC-PUFAs is had a very important significance.In order to improve life
Efficiency is produced, the desaturase for screening such efficient catalytic ARA synthesis EPA is particularly important.This will be building high yield ω -3LC-
The engineering bacteria of PUFAs, normal temperature fermentation produce EPA, DHA, lay a solid foundation.
[summary of the invention]
The purpose of the present invention is the methods using bioinformatics, obtain ω -3 desaturase of some room temperature preference 20C,
By constructing recombination engineering, each ω -3 desaturase catalysis ARA ability for generating EPA is identified, to obtain
The most desaturase of the efficient catalytic 20C ω -6LC-PUFAs synthesis ω -3LC-PUFAs of important application potentiality.
Thinking of the invention is that the ω -3 desaturase sequence of room temperature preference 20C known to 5 kinds is compared, according to sequence
Column similarity and homology analysis filter out the gene sequence from phytophthora parasitica close with known array similarity height, affinity
Column such as the SEQ ID NO.1 and gene order SEQ ID NO.5 from fungi medium silk capsule bacterium.It will using Clustal W2 software
Its amino acid sequence is compared with the ω -3 desaturase sequence of a variety of known room temperature preference 20C, finds natural come from
The gene order of phytophthora parasitica such as SEQ ID NO.1 and gene order SEQ ID NO.5 from fungi medium silk capsule bacterium possess
3 areas His-box similar with known array.By the analysis of TMHMM software, selected sequence has and known array as the result is shown
Similar transmembrane domain then carries out active verifying.
Further, the present invention constructs two sections of ω -3 desaturase sequences by optimization using full genome synthetic technology:
OPpFADS17 such as the SEQ ID NO.3 and oAiFADS17 such as SEQ ID NO.7.Target gene is amplified using round pcr
Segment, insertion PYES 2/NT C expression vector obtain PYES2/NT C-oPpFADS17 and PYES2/NT C-oAiFADS17 simultaneously
Sequence verification is completed, and then is transformed into saccharomyces cerevisiae INVSc 1 with chemical method, obtained recombinant strain can smoothly express two
The albumen of section gene coding.Activity is carried out finally by the polyunsaturated fatty acid substrate of external source addition different carbon chain lengths to test
Card determines that oPpFADS17, oAiFADS17 sequence of screening have ω -3 desaturase activity.
The present invention provides the coded sequence with ω -3 desaturase of specific catalytic 20C ability, nucleic acid sequence point
Not such as SEQ ID NO.3 and SEQ ID NO.7.
The present invention also provides the expression vector PUC57- respectively containing SEQ ID NO.3 and SEQ ID NO.7 nucleic acid sequence
OPpFADS17 and PUC57-oAiFADS17 can express ω -3 desaturation of phytophthora parasitica and fungi medium silk capsule bacterium respectively
Enzyme.
The present invention also provides the recombinations for ω -3 desaturase that can express phytophthora parasitica and fungi medium silk capsule bacterium respectively
Microorganism.Preferably, the recombinant microorganism is saccharomyces cerevisiae.
Successful expression of the present invention from phytophthora parasitica and fungi medium silk capsule bacterium, in polyunsaturated fatty acid biology
ω -3 the desaturase oPpFADS17 and oAiFADS17 to play a crucial role in route of synthesis, amino acid sequence is respectively such as SEQ
ID NO.4 and SEQ ID NO.8.
The invention further relates to above-mentioned ω -3 desaturase oPpFADS17 and oAiFADS17 in polyunsaturated fatty acid biology
Purposes in synthesis, especially at normal temperature by C20:4Δ5,8,11,14Catalysis is C20:5Δ5,8,11,14,17。
The present invention can be catalyzed 18C by experimental method two kinds of ω -3 desaturases of acquisition but also be catalyzed more insatiable hungers of 20C
And fatty acid, but prefer to convert EPA for the ARA of 20C, catalytic efficiency reaches 65%.With this gene constructed genetic engineering bacterium
Strain is that subsequent industrialized production EPA, DHA has established application foundation.
[Detailed description of the invention]
Fig. 1 is the target gene fragment figure of PCR amplification;
Wherein M is nucleic acid Marker;Swimming lane 1 is oPaFADS17 genetic fragment (1080bp);Swimming lane 2 is oPpFADS17 base
Because of segment (1086bp);Swimming lane 3 is oAiFADS17 genetic fragment (1095bp);
Fig. 2 is the agarose gel electrophoresis figure of the sub- PCR identification of saccharomyces cerevisiae recombinant conversion;
Wherein M is nucleic acid Marker;Swimming lane 1 is the carrier containing empty plasmid;Swimming lane 2-4 is INVSc 1-oPaFADS17's
1,2, No. 3 transformants;Swimming lane 5-7 is 1,2, No. 3 transformant of INVSc 1-oPpFADS17;Swimming lane 8-10 is INVSc 1-
1,2, No. 3 transformant of oAiFADS17;
Fig. 3 is the transcriptional level of each ω -3 desaturase transformant;
Fig. 4 is each ω -3 desaturase transformant vapor detection figure;
A is INVSc 1-oPpFADS17 vapor detection figure;
B is INVSc 1-oAiFADS17 vapor detection figure;
C is INVSc 1-oPaFADS17 vapor detection figure;
[specific embodiment]
Following embodiment for explaining technical solution of the present invention without limitation.
Embodiment 1: the determination of ω -3 desaturase of room temperature preference 20C
By the ω -3 desaturase sequence of room temperature preference 20C known to 5 kinds (gene OPIN 17, sdd 17, PsD 17,
PrD 17 and PaD 17) be compared in the library NCBI, according to sequence similarity and homology analysis, filter out two kinds with
Know the ω -3 desaturase gene order that sequence similarity is high, affinity is close, is respectively from phytophthora parasitica, fungi medium silk capsule
Bacterium, corresponding gene number is respectively XM_008906963, XM_008870610.Annotation of the library NCBI to this two sections of sequences
Fatty acid desaturase family is belonged to, but detailed annotation is not done to its concrete function.
By Clustal W2 software by preference 20C's known to the coding region sequence of above two sections of genes and aforementioned 5 kinds
ω -3 desaturase sequence carries out albumen comparison, and the above two sections of sequences of discovery have 3 His-box similar with known array
Area, i.e., the common ground of all ω -3 desaturases, the similar area His-box protein sequence are shown in Table 1.Pass through TMHMM software point
The above two sections of sequences of analysis discovery have transmembrane domain similar with known array.
3 His-box amino acid sequences of ω -3 desaturase of preference 20C under 1 room temperature of table
Embodiment 2: the building of recombinant expression carrier
1, target gene is obtained
Due to from the rotten mould gene order codon usage bias of phytophthora parasitica, fungi medium silk capsule bacterium and melon and fruit
Different from host's saccharomyces cerevisiae, so utilizing Genscript according to Eukaryotic codon usage bias
OptimumGeneTM system carries out codon optimization to its nucleic acid sequence, respectively the gene order after artificial synthesized optimization
OPpFADS17, oAiFADS17 and oPaFADS17 (for positive control), such as SEQ ID NO.3, SEQ ID NO.7 and SEQ ID
Then NO.11 connect to obtain PUC57-oPpFADS17, PUC57-oAiFADS17 and PUC57- with PUC57-simple carrier respectively
OPaFADS17, is stored in Escherichia coli Top10 and (buys from Nanjing of China Jin Sirui company).
According to oPpFADS17, oAiFADS17 and oPaFADS17, primers, each pair of primer adds restriction enzyme site
EcoR I and Xho I (at underscore).To contain plasmid PUC57-oPpFADS17, PUC57- of the above optimization gene respectively
OAiFADS17 and PUC57-oPaFADS17 is template, and with every kind of gene corresponding primer, KOD exo+ polymerase is expanded by PCR
Increasing obtains target gene fragment.PCR program are as follows: 94 DEG C of 30s, 55 DEG C of 30s, 68 DEG C of 1.5min, 30 circulations, 68 DEG C of 10min, and
PCR product is purified, purified product is verified with 1.0% agarose gel electrophoresis.As a result such as Fig. 1.
Primer sequence for amplifying target genes is as follows:
oPpFADS17F ctaattgaattcATGGCAACCAAGCAAGC
oPpFADS17R cgattctcgagTTAAGTTGACTTGGTTTTAACAGCG
oAiFADS17F acaatggaattcATGCCATCCCCTAAAGCCAC
oAiFADS17R cctgatctcgagTTATAAGGTCTTTTTAACTGAGTTTGCTCT
oPaFADS17F catgtagaattcATGGCTTCGTCCACCGTTG
oPaFADS17R ttacgactcgagTTAGTTAGCCTTGGTCTTGGCAG
2, endonuclease reaction:
Under the conditions of 37 DEG C, with restriction enzyme EcoR I and Xho I double digestion target gene fragment and carrier
PYES2/NT C carries out endonuclease reaction, digestion system (100 μ L) are as follows: 2 μ L EcoR I, 2 μ L Xho I, 30 μ L target gene/load
Body, 10 μ L cutsmart Buffer, 56 μ L deionized waters, 37 DEG C of incubation 12h.Digestion products Thermo Scientific
After GeneJET gel extraction kit kit carries out glue recycling, it is stored in -20 DEG C for use.
Wherein, 10 × cutsmart of inscribe enzyme buffer liquid Buffer:500mM potassium acetate, 200mM Tris- acetate are slow
Fliud flushing, 100mM magnesium acetate, 1000 μ g/mL bovine serum albumin(BSA)s, pH 7.9.
3, connection reaction:
With T4 ligase be separately connected target gene fragment oPpFADS17, oAiFADS17, oPaFADS17 after purification and
Carrier PYES2/NT C, 4 DEG C of incubation 12h, linked system are as follows: PYES2/NT C carrier (50ng/ μ L) 1 μ L, genetic fragment 75-
1 μ L, T4 ligase of 150ng, buffer, 1 μ L, moisturizing to 10 μ L.
Wherein, 10 × ligase buffer:660mM Tris- hydrochloride buffer (pH 7.6), 66mM magnesium chloride, 100mM
Two sulphur threoses, 1mM atriphos.
4,10 competent cell of Escherichia coli TOP is converted:
Method for transformation is as follows:
1) 100 μ L competent cells are taken under germ-free condition, 1-2 μ L connection product is added, and pressure-vaccum mixes.
2) competent cell in above-mentioned steps is moved into electric revolving cup, avoids generating bubble.
3) electric revolving cup is put into Bio-Rad electroporation, is transferred to desired preset program gear, operating instruction is used according to instrument
Carry out electrotransformation, voltage conditions 1.8kv.
4) competent cell after conversion is moved in the centrifuge tube containing 1mL SOC recovery medium, 37 DEG C, 150rpm
It is incubated for 1h.
5) 200 μ L is taken to be coated on the LB solid medium tablets containing 100 μ g/mL ammonia benzyl mycins.37 DEG C are inverted to cultivate
Night.
Picking positive transformant extracts plasmid and is sequenced, and sequencing result and gene order exactly match, and shows to connect into
Function obtains expression vector, is respectively designated as PYES2/NT C-oPpFADS17, PYES2/NT C-oAiFADS17, PYES2/NT
C-oPaFADS17。
Wherein, the composition of SOC recovery medium are as follows: 20g/L tryptone, 5g/L yeast extract, 0.5g/L sodium chloride,
2.5mM potassium chloride, 10mM magnesium chloride, 20mM glucose.
The composition of LB solid medium is: 10g/L tryptone, 5g/L yeast extract, 10g/L sodium chloride, 20g/L fine jade
Rouge.
One saccharomyces cerevisiae INVSc 1 of picking (being purchased from U.S. hero company) is cloned in 10mL YPD culture medium, 30 DEG C
It is incubated overnight.OD600 is surveyed, a certain amount of bacterium solution of transferring makes OD value 0.4 in 50mL culture medium, continues to cultivate 2-4h.2500rpm from
The heart 1 × TE of 3min, 40mL is resuspended.2500rpm is centrifuged 3min, and 1 × LiAc/0.5X of 2mL TE is resuspended, and is incubated at room temperature 10min.
The sterilised yeast suspension of 100 μ l previous steps is taken to each transformant of embodiment 2, and 1 μ g recombinant expression carrier plasmid is added
DNA and 100 μ g salmon essence carrier DNA.In order to obtain optimal transformation efficiency, repeat to become carrier DNA before conversion every time
Property processing, boiling water bath 2min, ice bath 2min, quadruplication.700 1 × LiAc/40wt%PEG-3350/1 of μ l × TE is added, mixes
It is even.30 DEG C of incubation 30min.88 μ l DMSO are added, are mixed, 42 DEG C of shock 7min.It is centrifuged 10s, removes supernatant.1 × TE of 1mL is added
It is resuspended, is centrifuged again.Thallus is resuspended in 50-100 1 × TE of μ l, is applied to SC and selects to support on base plate.30 DEG C of culture 2-5d.
Wherein 1 × TE:10mM Tris- hydrochloride buffer (PH=8.0), 1mM ethylenediamine tetraacetic ethanol amine (PH=8.0);1
× LiAc:10mM lithium acetate.
YPD culture medium composition are as follows: 10g/L yeast extract, 20g/L peptone, 20g/L glucose.
Wherein SC Selective agar medium are as follows: 6.7g/L yeast nitrogen (no amino acid has ammonium sulfate), 20g/L glucose, 0.1g/
L (respectively adenine, arginine, cysteine, leucine, lysine, threonine, tryptophan), (the respectively day 0.05g/L
Aspartic acid, histidine, isoleucine, methionine, phenylalanine, proline, serine, tyrosine and valine), 20g/L
Agar powder.
The PCR verifying of experimental example 4, Saccharomyces cerevisiae transformant
The good colony inoculation of growth conditions is picked from the plate into the YPD culture medium of the 5mL resistance of benzyl containing ammonia, 30 DEG C
200rpm cultivates 48h, with plasmid extraction kit (being purchased from Tiangeng company) extracting plasmid, measures A 260nm and A 280nm value,
Calculate the concentration of plasmid, cryo-conservation.
PCR identification is carried out with corresponding primer.Primer is as follows:
T7 TAATACGACTCACTATAGGG
T7 terminator TCGGTTAGAGCGGATGTG
PCR reaction system is as follows: dd H27 μ L, 10 × Taq MIX of O 10 μ L, 1 μ L of universal primer T7, universal primer
1 μ L of T7terminator, 1 μ L of template (plasmid).PCR reaction condition: 94 DEG C of 5min, 94 DEG C of 30s, 58 DEG C of 30s, 72 DEG C
1.5min, 30 circulations, 72 DEG C of 7min.3 μ L PCR products are taken to carry out 1wt% agarose gel electrophoresis after amplified reaction,
PCR product stripe size is detected, as shown in Figure 2.
Each gene respectively obtains 3 transformants as seen from Figure 2.Recombinant conversion is respectively designated as INVSc 1-
OPpFADS17 1-3, INVSc 1-oAiFADS17 1-3 and INVSc 1-oPaFADS17 1-3 are protected in 30wt% glycerol tube
Hiding.The PYES2/NT C empty carrier of genetic fragment is not inserted into as negative control group.
Experimental example 5: the sub- Fiber differentiation of Saccharomyces cerevisiae transformant
Single colonie on the sub- plate of picking Saccharomyces cerevisiae transformant is inoculated in seed culture medium SC-U, 28 DEG C of culture 48h, measurement
OD600Value.It transfers into induced medium, OD value is made to reach 0.4, while the polyunsaturated fat of external source addition different carbon chain lengths
Sour substrate.28 DEG C of culture 48h collect thallus.
Wherein seed culture medium SC-U are as follows: 6.7g/L yeast nitrogen (no amino acid has ammonium sulfate), 20g/L glucose,
0.1g/L (has adenine, arginine, cysteine, leucine, lysine, threonine, tryptophan and uracil) respectively,
0.05g/L (has aspartic acid, histidine, isoleucine, methionine, phenylalanine, proline, serine, tyrosine respectively
And valine).
Induced medium is the carbon source of seed culture medium to be changed to 10g/L raffinose, and add 20g/L inducer gala
Sugar.
Experimental example 6: the transcriptional level measurement of Saccharomyces cerevisiae transformant
Extract the sub- total serum IgE of Saccharomyces cerevisiae transformant, specific steps are as follows:
1) thallus frozen in liquid nitrogen in right amount is taken out, liquid nitrogen is added in the sterile no enzyme mortar of pre-cooling and is fully ground.
2) 1mL TRIzol (buying from Invitrogen company, the U.S.) is added to continue to be ground to powder, is placed at room temperature for molten
Solution.
3) 1mL aforesaid liquid is drawn in no enzyme centrifuge tube with no enzyme pipette tips, 200 μ L chloroforms are added and mix.
4) 4 DEG C of centrifugation 15min of 12000rpm are sucted clearly in new no enzyme centrifuge tube.
5) 200 μ L chloroforms are added to mix, 4 DEG C of centrifugation 15min of 12000rpm are sucted clearly in new no enzyme centrifuge tube
In.
6) isometric isopropanol is added, stands 15min, 4 DEG C of centrifugation 15min of 12000rpm.Supernatant is abandoned, room temperature is dried.
7) 1mL 70vol% ethyl alcohol, 4 DEG C of centrifugation 15min of 12000rpm are added.Ethyl alcohol is sucked with no enzyme pipette tips, room temperature is put
Set drying.
8) 50 μ L are added and dissolve RNA, -80 DEG C of storages without enzyme water.
9) concentration mensuration: 1 μ L RNA is taken to measure concentration with NaNodrop 2000.
10) denaturation gel electrophoresis detects RNA integrality: taking 1 μ g RNA electrophoresis in the denaturation glue of 1.2wt%, observation RNA is complete
Whole property.
It is set according to oPpFADS17, oAiFADS17, oPaFADS17 gene order and saccharomyces cerevisiae internal reference 18S rDNA sequence
Count qRT-PCR primer:
q-oPpFADS17F GGCAACCAAGCAAGCCTATGTA
q-oPpFADS17R GCTAAGGCAACTGCAATTACCAAAC
q-oAiFADS17F TACTACTTCGCTCCATTGTTCGTTT
q-oAiFADS17R CAACCGTAGGATCTATCAACTGAAG
q-oPaFADS17F CTTCGTCCACCGTTGCTG
q-oPaFADS17R AGCCAGCGATTCCGAGA
18S-F AATCATCAAAGAGTCCGAAGACATTG
18S-R CCTTTACTACATGGTATAACTGTGG
Taking 0.5-1 μ g total serum IgE is template, (public purchased from Japan TaKaRa according to PrimeScript RT reagent kit
Department) kit illustrates to be operated, obtain the cDNA of recombinant bacterial strain.Use ABI-Prism 7900sequence detection
System (Applied Biosystems, CA) is according to SYBR Green PCR Master Mix (Applied
Biosystems, CA) illustrate carry out RT-qPCR reaction.
Reaction system are as follows: 10 μ l SYBR Green PCR Master Mix, each each 0.5 μ l of gene upstream and downstream primer, 8 μ l
Without enzyme water, 1 μ l template.PCR cycle is set as 50 DEG C of 2min, 95 DEG C of 10min, 95 DEG C of 15s, 60 DEG C of 30s, 40 circulations.Wine brewing
The 18S rRNA of yeast is as reference gene.
According to 2-ΔΔCtMethod calculates the relative transcript levels of gene, and wherein all samples survey three repetitions, in which: Δ Δ Ct
=Δ Ct (sample)-Δ Ct (control)
As a result as shown in Figure 3.Analysis finds that each gene transformants reach 10 or so compared with control group, Δ Δ Ct value, it was demonstrated that
The expression quantity of this gene is changed from scratch, shows successfully to transcribe in host strain.
Experimental example 7: the protein expression measurement of saccharomyces cerevisiae
With identical condition, after being induced respectively the different transformants of different genes, bacterium is crushed with 0.5mm pickling glass pearl
Body extracts total protein of cell.
After measuring protein concentration with BSA method, SDS-PAGE electrophoresis is carried out with the applied sample amount of 100 μ g total proteins, until Marker
It is kept completely separate.
It will be on the protein delivery to pvdf membrane in protein gel in Bio-Rad electrophoresis apparatus.Transferring film condition is 20mA, mistake
Night.
After the completion of transferring film, pvdf membrane is immersed in TBST buffer, in being incubated at room temperature 10min on horizontal shaker.It repeats
Three times.
Pvdf membrane is immersed in the TBST buffer of the skimmed milk containing 5wt%, in being incubated at room temperature 90min on horizontal shaker.
Pvdf membrane is immersed in TBST buffer in being incubated at room temperature 10min on horizontal shaker.In triplicate.
Anti- His primary antibody is dissolved in horizontal shaker in the TBST buffer containing 5wt% skimmed milk with the ratio of 1:5000 to incubate
Educate 1h.
Pvdf membrane is immersed in TBST buffer in being incubated at room temperature 10min on horizontal shaker.In triplicate.
Sheep anti mouse secondary antibody is dissolved in the TBST buffer level shaking table containing 5wt% skimmed milk with the ratio of 1:10000 to incubate
Educate 1h.
Pvdf membrane is immersed in TBST buffer in being incubated at room temperature 10min on horizontal shaker.In triplicate.
Pvdf membrane ECL method is developed.It exposes and takes pictures in western imager.
The result shows that the different transformant albumen of different genes are expressed, and different transformant expressing quantities are several
It is consistent.
Wherein TBST buffer (1L) forms are as follows: 8.8g sodium chloride;20mL 1M Tris-HCl pH of buffer 8.0;
0.5mL polysorbas20.
Embodiment 8: the extraction of saccharomyces cerevisiae fatty acid
The following steps are included:
Collect thallus after inducing, vacuum freeze drying.
It is fully ground crushing, 10mg is weighed and 1mL 10wt% methanol hydrochloride solution is added (i.e. containing the first of 10wt%HCl
Alcohol), internal standard (each 100 μ l of C15:0, C21:0), oscillation mixes.60 DEG C of water-bath 3h, it is primary every 0.5h concussion.
1mL n-hexane is added and the oscillation of 1mL saturated sodium-chloride mixes, 4000rpm is centrifuged 5min.Take supernatant to clean bottle
In.
1mL n-hexane is taken to be added on former bottle, 4000rpm is centrifuged 5min, takes supernatant in above-mentioned new bottle.
Liquid N in new bottle2Drying.1mL n-hexane is added, screws lid, it is molten to obtain fatty acid methyl ester for oscillation dissolution
Liquid.
Gained fatty acid methyl ester analysis use GC-MS (Shimadzu Co., Japan), chromatographic column be Rtx-Wax (30m ×
0.25mm, 0.25 μm).Mass detector detection is carried out, vaporizing chamber and detector temperature are respectively 240 DEG C and 250 DEG C, shunting side
1 μ L of formula sample introduction, split ratio 10:1, carrier gas is helium.
Temperature programming: 40 DEG C of holding 5min of initial temperature are raised to 150 DEG C with 20 DEG C/min, then be raised to 190 with 5 DEG C/min
DEG C, 5min is kept, is finally raised to 220 DEG C with 5 DEG C/min, keeps 17min.By being protected with fatty acid methyl ester standard items (C15:0)
Stay time, peak area ratio pair and mass spectrometry results, fatty acid component in qualitative, quantitative sample.
Embodiment 9: the ω -3 desaturase activity identification of room temperature preference 20C
The ARA that three concentration gradients 0.05mM, 0.1mM, 0.2mM are added in induced medium is lured as substrate
It leads, collects thallus, extract fatty acid, GC-MS determination of fatty acid result is as shown in Figure 4.
Compared with Ctrl group, INVSc 1-oPpFADS17, INVSc 1-oAiFADS17, INVSc 1-oPaFADS17 exist
Occur new peak in 37.5min, by comparing with fatty acid methyl ester standard items and mass spectral analysis, determines this peak for EPA.Specific point
Analysis the results are shown in Table 2
Catalytic efficiency of 2 difference ω -3 desaturase saccharomyces cerevisiae recombinant conversion of table to ARA
Three transformants of INVSc 1-oPpFADS17 are to the catalytic efficiency highest of ARA, wherein INVSc 1-
OPpFADS17 3 respectively reaches 64.8%, 49.0%, 43.8% under three concentration gradients, with positive control INVSc 1-
Catalytic efficiency 69.7% of the oPaFADS17 under three concentration, 48.4%, 39.5% almost without difference, and absolute yield into
One step is better than each transformant of positive control.
Particularly, with the prior art < Identification and characterization of new Δ -17
Fatty acid desaturases > middle recombination solution rouge yeast recorded is compared, INVSc 1-oPpFADS17 conversion of the invention
Son when realizing comparable catalytic conversion, needed for induced medium in substrate A RA concentration significantly reduce, especially exist
Maximum conversion is realized under 0.05mM, and EPA yield also further increases, show better EPA conversion capability.In addition, this
It invents in the expression vector saccharomyces cerevisiae used only containing 9 fatty acid dehydrogenase of Δ, i.e., only has linoleic acid and palm fibre in saccharomyces cerevisiae
Two kinds of monounsaturated fatty acids of palmitic acid oleic acid, compared with existing recombination solves rouge yeast, recombinant Saccharomyces cerevisiae of the invention will not be done
The polyunsaturated fatty acid route of synthesis to be utilized is disturbed, and has His label on recombinant vector of the invention, is more advantageous to subsequent
The purifying and identification of albumen.
In addition, above data is found out, the ω -3 desaturase gene order from fungi medium silk capsule bacterium is although with coming from
ω -3 desaturase the gene order of phytophthora parasitica has the characteristics that similarity is high, affinity is close, but passes through same technique means
The recombinant bacterium of acquisition cannot but play identical effect.Transformant INVSc 1-oAiFADS17 from fungi medium silk capsule bacterium
Catalytic efficiency it is relatively low, respectively 46.3%, 33.5%, 23.9%.It is whether inclined in order to further verify this several sections of genes
It is catalyzed the substrate of 20C well, chooses INVSc 1-oPpFADS17 3, INVSc 1-oAiFADS17 3 and INVSc 1-
1 three plant weight group transformant of oPaFADS17 adds 0.2mM LA, GLA, DGLA, ARA and simultaneously in induced medium respectively
Addition 0.1mM LA and 0.1mM ARA is induced respectively, as a result such as table 3.
Catalytic efficiency of 3 28 DEG C of difference ω -3 desaturation saccharomyces cerevisiae recombinant conversion of table to different substrates
Analysis is it is found that recombinant conversion sub- INVSc 1-oPpFADS17 3 and INVSc 1-oAiFADS17 3, INVSc 1-
OPaFADS17 1 is significantly higher than 18C substrate to the conversion ratio of 20C substrate, wherein the transformation efficiency to ARA is particularly evident.INVSc
Conversion ratio highest of the 1-oPpFADS17 3 to ARA, yield suitable with the conversion ratio of positive control INVSc 1-oPaFADS17 1
Then it is higher than positive control;In addition, INVSc 1-oPpFADS17 3 is positive control to the conversion ratio of the ω -6PUFAs other than ARA
Twice or so, illustrate that the efficiency of recombinant bacterium synthesis ω -3PUFAs of the invention is apparently higher than positive control.
In order to prove that ω -3 desaturase up to phytophthora parasitica in room temperature and higher compared with catalytic activity under low temperature, is luring
Lead culture medium addition 0.2mM LA, GLA, DGLA, ARA and add 0.1mM LA and 0.1mM ARA simultaneously, under the conditions of 12 DEG C into
Row induction, as a result such as table 4.
Catalytic efficiency of 4 12 DEG C of difference ω -3 desaturation saccharomyces cerevisiae recombinant conversion of table to different substrates
From the determination of fatty acid of table 4, the result shows that, the conversion ratio under different recombinant bacterium low temperature decreases.However,
The recombinant Saccharomyces cerevisiae bacterium that phytophthora parasitica ω -3 desaturase can be expressed in the present invention has at relatively low temperatures is significantly higher than energy
The EPA conversion ratio and EPA yield for enough expressing the recombinant Saccharomyces cerevisiae bacterium of ω -3 desaturase of fungi medium silk capsule bacterium, also superior to
The EPA conversion ratio and EPA yield of the recombinant Saccharomyces cerevisiae bacterium of rotten mould ω -3 desaturase of melon and fruit can be expressed.
In conclusion ω -3 desaturase obtained through the invention can be catalyzed 18C and be catalyzed more insatiable hungers of 20C
And fatty acid, but the ARA of 20C is converted EPA by preference, and transformation efficiency is higher at normal temperature, furthermore synthesizes ω -3PUFAs's
Efficiency is further better than the prior art.It is that subsequent industrialized production EPA, DHA is established with this gene constructed engineering strain
Application foundation.
Although the invention patent has been described by way of example and in terms of the preferred embodiments, it is not intended to limit the invention.It is any to be familiar with
The people of this technology can do various changes and modification without departing from the spirit and scope of the present invention.Therefore protection of the invention
Range should subject to the definition of the claims.
Claims (1)
1. the recombinant Saccharomyces cerevisiae bacterium of phytophthora parasitica ω -3 desaturase can be expressed in polyunsaturated fatty acid biosynthesis
Purposes, encode the recombination amino acid sequence of phytophthora parasitica ω -3 desaturase as shown in SEQ ID NO. 4, feature
It is the recombinant Saccharomyces cerevisiae bacterium at normal temperature by C20:4Δ5,8,11,14 Catalysis is C20:5Δ5,8,11,14,17, catalytic efficiency reaches
To 65%.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510902579.5A CN105368851B (en) | 2015-12-09 | 2015-12-09 | A kind of omega-3 desaturase derived from Phytophthora parasiticus, carrier containing said desaturase, recombinant microorganism and application thereof |
US16/060,417 US10533232B2 (en) | 2015-12-09 | 2016-12-08 | Parasitic phytophthora-derived omega-3 fatty acid desaturase for synthesizing polyunsaturated fatty acids, carrier containing fatty acid desaturase, recombinant microorganisms, and application thereof |
PCT/CN2016/108983 WO2017097218A1 (en) | 2015-12-09 | 2016-12-08 | Parasitic phytophthora-derived ω-3 fatty acid desaturase for synthesizing polyunsaturated fatty acids, carrier containing fatty acid desaturase, recombinant microorganisms, and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510902579.5A CN105368851B (en) | 2015-12-09 | 2015-12-09 | A kind of omega-3 desaturase derived from Phytophthora parasiticus, carrier containing said desaturase, recombinant microorganism and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105368851A CN105368851A (en) | 2016-03-02 |
CN105368851B true CN105368851B (en) | 2019-05-07 |
Family
ID=55371480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510902579.5A Active CN105368851B (en) | 2015-12-09 | 2015-12-09 | A kind of omega-3 desaturase derived from Phytophthora parasiticus, carrier containing said desaturase, recombinant microorganism and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105368851B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017097218A1 (en) * | 2015-12-09 | 2017-06-15 | 江南大学 | Parasitic phytophthora-derived ω-3 fatty acid desaturase for synthesizing polyunsaturated fatty acids, carrier containing fatty acid desaturase, recombinant microorganisms, and application thereof |
CN105647822B (en) * | 2016-03-28 | 2020-03-10 | 江南大学 | Recombinant mortierella alpina for overexpression of omega-3 desaturase from phytophthora parasitica as well as construction method and application thereof |
CN105567579A (en) * | 2016-03-07 | 2016-05-11 | 江南大学 | Recombinant strain for expressing heterogenous Omega-3 desaturase in mortierella alpina and construction method thereof |
CN110373437B (en) * | 2018-12-11 | 2022-09-27 | 山东理工大学 | Construction and fermentation technology of a cell factory of stearidonic acid-producing Mucor peregrine |
CN109517854B (en) * | 2018-12-13 | 2020-12-29 | 江南大学 | A kind of Δ17 desaturase derived from arbuscular mycorrhizal fungi and its application |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101646766A (en) * | 2006-04-20 | 2010-02-10 | 纳幕尔杜邦公司 | Detal 17 desaturases and their use in making polyunsaturated fatty acids |
CN102776213A (en) * | 2012-08-28 | 2012-11-14 | 江南大学 | Desaturase omega 3 Des for biosynthesis of polyunsaturated fatty acids |
CN103820335A (en) * | 2014-03-11 | 2014-05-28 | 江南大学 | Mortierella alpina, M. alpina genetic engineering strain of overexpression omega 3 desaturase gene and construction method of strain |
-
2015
- 2015-12-09 CN CN201510902579.5A patent/CN105368851B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101646766A (en) * | 2006-04-20 | 2010-02-10 | 纳幕尔杜邦公司 | Detal 17 desaturases and their use in making polyunsaturated fatty acids |
CN102776213A (en) * | 2012-08-28 | 2012-11-14 | 江南大学 | Desaturase omega 3 Des for biosynthesis of polyunsaturated fatty acids |
CN103820335A (en) * | 2014-03-11 | 2014-05-28 | 江南大学 | Mortierella alpina, M. alpina genetic engineering strain of overexpression omega 3 desaturase gene and construction method of strain |
Non-Patent Citations (2)
Title |
---|
Identification and characterization of new Δ-17 fatty acid desaturases;XUE,Zhixiong等;《Appl.Microbiol.Biotechnol.》;20120527;第97卷;第1973-1985页 |
Phytophthora parasitica INRA-310 hypothetical protein mRNA;RUSS,C.等;《GenBank》;20140827;NCBI Reference Sequence:XM_008906963.1 |
Also Published As
Publication number | Publication date |
---|---|
CN105368851A (en) | 2016-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105368851B (en) | A kind of omega-3 desaturase derived from Phytophthora parasiticus, carrier containing said desaturase, recombinant microorganism and application thereof | |
CN103820335B (en) | Mortierella alpina, M. alpina genetic engineering strain of overexpression omega 3 desaturase gene and construction method of strain | |
CN103014053B (en) | Synechocystis efficient double homologous recombinant vector as well as construction method and application thereof | |
CN106591258B (en) | A kind of lipase gene, vector, engineering bacteria and application thereof | |
CN102776213B (en) | Desaturase omega 3 Des for biosynthesis of polyunsaturated fatty acids | |
CN102399796B (en) | Bacillus megaterium ALA2 cytochrome P450 enzyme gene and methods of recombinant plasmid construction and enzyme purification | |
CN102295691B (en) | BCCP2 gene and application on enhancing lipid content of plant and algae thereof | |
CN103525842B (en) | A Δ12-fatty acid dehydrogenase gene and its recombinant expression vector | |
CN107384979B (en) | Application of high osmotic pressure glycerol protein kinase gene RKHog1 | |
CN103710315A (en) | Long-chain acyl-coenzyme A synthetase from Cordyceps sinensis, gene thereof, and applications of synthetase and gene | |
WO2015115583A1 (en) | Modified cyanobacteria | |
Wang et al. | A simple and efficient transformation system for the edible mushroom Pleurotus eryngii | |
CN103525841B (en) | A Δ12-fatty acid dehydrogenase gene and its recombinant expression vector | |
CN103834672B (en) | A Δ12-fatty acid dehydrogenase gene and its application | |
CN102373229B (en) | Saccharomyces oleaginosus delta12 and delta15 difunctional fatty acid desaturase gene and cloning method thereof | |
US10533232B2 (en) | Parasitic phytophthora-derived omega-3 fatty acid desaturase for synthesizing polyunsaturated fatty acids, carrier containing fatty acid desaturase, recombinant microorganisms, and application thereof | |
CN104099334B (en) | MicroRNAs gene and improve chlorella content of fatty acid application | |
CN102676548B (en) | Latropha curcas delta9 fatty acid dehydrogenase mutant and encoding genes, recombinant plasmids, host cells and application thereof | |
CN109628473A (en) | It is a kind of for improve volume branch Mucor oil production four dicarboxyl acid transporter of carbon | |
CN113930379B (en) | Beta-alanine producing strain, construction method and application | |
CN102373189A (en) | Fatty acid synthesis-related protein and encoding gene and application thereof | |
CN100487121C (en) | Nucleotide sequence of Pichia pastoris ω3-fatty acid dehydrogenase and its application | |
CN102559710B (en) | Isochrysis sphaerica delta 4-fatty acid desaturase gene and cloning method thereof | |
CN109517854B (en) | A kind of Δ17 desaturase derived from arbuscular mycorrhizal fungi and its application | |
CN110029092B (en) | A kind of glyceraldehyde 3-phosphate dehydrogenase and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |